And while metformin has been the first-line therapy in treating type 2 diabetes, the FDA announced in 2019 that Rybelsus (semaglutide), a GLP-1, can also be offered as a first-line treatment
You will start on a low dose of 0.25mg, which increases every 4 weeks until you reach the highest 2mg dose, or your blood sugar levels are under control
Patients taking tirzepatide should inform their provider about NSAID use, report any signs of GI bleeding (dark stools, coffee-ground emesis), and schedule kidney function tests before and during NSAID therapy
"Amylin Receptor Agonists: Mechanisms of Action in Metabolic Disease." Nature Reviews Endocrinology, 2023, 19(8): 467-481
Longer term For longer repeated exposure, review broad health, inflammation, and copper-context markers every 3-6 months with a clinician
Clinical research offers more reliable context than isolated online photos